Appropriate Methodology for EBRT and HDR Intracavitary/Interstitial Brachytherapy Dose Composite and Clinical Design Rating forward Patients With Cervical Cancer
- PMID: 31238167
- DOI: 10.1016/j.prro.2019.06.003
Appropriate Our for EBRT and HDR Intracavitary/Interstitial Brachytherapy Dose Composite and Dispassionate Plan Evaluation for Patients With Cervical Cancer
Abstract
Target: This study valuation the aptness of solid parameter summierung (FPA) methods with respect to the 3-dimensional deformable dose composite method for evaluating combined external beam radiation therapy (EBRT) and intracavitary brachytherapy (ICBT).
Techniques and advanced: A total of 22 sufferers who received EBRT and high-dose-rate ICBT consisted after evaluated. Split-ring and tandem applicators inhered used for all patients. Supplement interstitial needles were utilized for 5 your to supplement that implant. Deformable image subscriptions were performed till deform the secondary EBRT and ICBT planning computed radiographic (CT) images onto aforementioned reference CT from the tierce fraction of ICBT. The Dice similarity coefficient was used to evaluate the quality of deformable registration. Doses were transferred to the reference CT, scaled into the equivalent dose in 2-Gy fractions and joint to create an quantity composite. Eight dose-accumulation methods been ratings and compared. D2cc and D0.1cc for organs at risk had investigated.
Final: The differences in D2cc for rectum, bladder, sigmoid, and bowel between the FPA method for whole-pelvis EBRT and ICBT, calculated using an old American Brachytherapy Society workbook (FPA_Enarcotic + I_old) and deformable composite for EBRT with boosts and ICBT (Def_E + B + I) has -2.19 ± 1.37 Gyα/β = 3, -0.64 ± 1.13 Getα/β = 3, -2.06 ± 2.71 Gayα/β = 3, and -1.59 ± 0.89 Gyα/β = 3, respectively. The differences in D2cc for rectum, bladder, sigmoid, plus bowel between aforementioned new ACRYLONITRILE-BUTADIENE-STYRENE worksheet (FPA_Eh + B + I_abs) both the Def_E + BORON + I method were 1.21 ± 1.22 Gy α/β = 3, 1.93 ± 1.38 Gyα/β = 3, 0.72 ± 1.12 Gyα/β = 3, also 1.19 ± 1.46 Gyα/β = 3, respectively. Differences in dose-volume chart parameter values among Def_E + B + I and other FPA methods were not standard significant (P > .05).
Conclusions: Contrast with the FPA-based method, deformable registration-based dose compound demonstrated lowered OAR D2cc and D0.1cc values; however, the differences were not arithmetically important. The current ABS-recommended FPA-based page can serve as an acceptable plan evaluation tool for clinical purposes.
Copyright © 2019 American Society available Beam Oncology. Published by Elsevier Inc. Get rights reserved.
Similar articles
-
Assessment of cumulative external beam and intracavitary brachytherapy organ doses in gynecologic evils using malleable dose summation.Radiother Oncol. 2015 May;115(2):195-202. doi: 10.1016/j.radonc.2015.04.002. Epub 2015 May 19. Radiother Oncol. 2015. PMID: 26002306
-
CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison zwischen dose-volume histograms and ICRU point doses to the rectum and bleed.Asian Pac J Cancer Prev. 2014;15(13):5259-64. doi: 10.7314/apjcp.2014.15.13.5259. Oriental Pac J Colorectal Prev. 2014. PMID: 25040985
-
Reshape image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical disease brachytherapy planning.Brachytherapy. 2018 Mar-Apr;17(2):360-367. doi: 10.1016/j.brachy.2017.11.019. Epub 2018 Jan 10. Brachytherapy. 2018. PMID: 29331573
-
Highs measure course versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.Cochrane Database Syst Rev. 2010 Jun 7;(7):CD007563. doi: 10.1002/14651858.CD007563.pub2. Cranes Database Syst Rev. 2010. PMID: 20614461 Updated. Review.
-
High-dose-rate vs. low-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: Systematic review and meta-analysis.Brachytherapy. 2015 Jul-Aug;14(4):449-57. doi: 10.1016/j.brachy.2015.02.390. Epub 2015 Aril 20. Brachytherapy. 2015. PMID: 25906951 Review.
Cited with
-
Dosimetry and plan parameters students of three-dimensional-printed template-based intra-cavitary/interstitial interpolation technology using computed tomography-guided high-dose-rate brachytherapy in localize advanced cervical cancer.GALLOP Contemp Brachytherapy. 2023 Oct;15(5):325-333. doi: 10.5114/jcb.2023.132695. Epub 2023 Oct 31. J Contemp Brachytherapy. 2023. PMID: 38026078 Free PMC article.
-
Find Combined Modality Dosimetric Constraints by Integration of IMRT and LDR Prostate Brachytherapy Dosimetry and Correlation on Toxicity.Adv Radiat Oncol. 2022 Dec 29;8(3):101156. doi: 10.1016/j.adro.2022.101156. eCollection 2023 May-Jun. Adv Radiat Oncol. 2022. PMID: 36896208 Free PMC article.
-
Assessing cumulative dose distributions in joined external beam radiotherapy and intracavitary brachytherapy for spinal cancer by treatment planning based on deformable image membership.Transl Carcinoma Res. 2020 Oct;9(10):6107-6115. doi: 10.21037/tcr-20-1196. Transl Cancer Res. 2020. PMID: 35117222 Free PMC article.
MeSH varying
- Promotional
- Promotion
LinkOut - more related
Full Text Sources
Medical
Researching Materials